| Cat.No. | Name | Information |
|---|---|---|
| M41831 | Retatrutide TFA | Retatrutide (LY3437943) TFA is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). |
| M41829 | FC382K10W15 TFA | FC382K10W15 TFA is a glucagon analogue and GLP-1R/GCGR agonist. |
| M41826 | Mazdutide TFA | Mazdutide (IBI-362; LY-3305677) TFA is an glucagon-like peptide-1 (GLP-1R)/glucagon receptor GCGR co-agonist, and a long-acting synthetic oxyntomodulin analog. |
| M40750 | AZD9550 | AZD9550 is a GLP-1R/GCGR dual agonist that may be used in studies related to non-alcoholic steatohepatitis (NASH). |
| M40588 | Efinopegdutide | Efinopegdutide is a dual agonist of GCGR and GLP-1R and may be used in studies related to non-alcoholic fatty liver disease (NAFLD). |
| M40587 | Bamadutide | Bamadutide is a compound that acts on GLP-1R and GCGR. |
| M40581 | MK-8521 | MK-8521 is a compound that acts on GLP-1R and GCGR. |
| M40528 | HM15136 | HM15136 is a novel long-acting glucagon analog that is also a glucagon receptor (GCGR) agonist for studies related to congenital hyperinsulinemia. |
| M40527 | HM15211 | HM15211 is a novel, long-acting GLP-1R/GCGR/GIPR triple agonist for studies related to non-alcoholic steatohepatitis (NASH). |
| M31110 | V-9-M cholecystokinin nonapeptide | V-9-M cholecystokinin nonapeptide is a glucagon-like peptide-1 (GLP-1) receptor agonist. |
| M30905 | Boc5 | Boc5 is a non-peptidic glucagon-like peptide-1 receptor agonist. Boc5 causes sustained glycemic control and weight loss in diabetic mice. Boc5 can be used in research of diabetic. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
